Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study

• Main Authors: Pablo Fernandez-Crehuet (Author), Sofía Haselgruber (Author), Alicia Padial-Gomez (Author), Fiorella Vasquez-Chinchay (Author), Maria Dolores Fernandez-Ballesteros (Author), Irene López-Riquelme (Author), David Jimenez-Gallo (Author), Juan Manuel Segura-Palacios (Author), Marisol Contreras-Steyls (Author), Giovana Fernanda Osorio-Gómez (Author), Juan Carlos Hernández-Rodríguez (Author), Manuel Sanchez-Diaz (Author), Carlos Cuenca-Barrales (Author), Salvador Arias-Santiago (Author), Alejandro Molina-Leyva (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Biologic drugs have a key role in the long-term anti-inflammatory treatment of moderate to severe patients due to their immunomodulatory properties. The aim of this study is to evaluate the effectiveness and...